BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20553613)

  • 1. Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung.
    Kalinina T; Güngör C; Thieltges S; Möller-Krull M; Penas EM; Wicklein D; Streichert T; Schumacher U; Kalinin V; Simon R; Otto B; Dierlamm J; Schwarzenbach H; Effenberger KE; Bockhorn M; Izbicki JR; Yekebas EF
    BMC Cancer; 2010 Jun; 10():295. PubMed ID: 20553613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
    Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
    Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis.
    Niess H; Camaj P; Renner A; Ischenko I; Zhao Y; Krebs S; Mysliwietz J; Jäckel C; Nelson PJ; Blum H; Jauch KW; Ellwart JW; Bruns CJ
    Target Oncol; 2015 Jun; 10(2):215-27. PubMed ID: 24950733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of six cell lines established from human pancreatic adenocarcinomas.
    Kato M; Shimada Y; Tanaka H; Hosotani R; Ohshio G; Ishizaki K; Imamura M
    Cancer; 1999 Feb; 85(4):832-40. PubMed ID: 10091760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selectin binding is essential for peritoneal carcinomatosis in a xenograft model of human pancreatic adenocarcinoma in pfp--/rag2-- mice.
    Gebauer F; Wicklein D; Stübke K; Nehmann N; Schmidt A; Salamon J; Peldschus K; Nentwich MF; Adam G; Tolstonog G; Bockhorn M; Izbicki JR; Wagener C; Schumacher U
    Gut; 2013 May; 62(5):741-50. PubMed ID: 22490524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity.
    Loukopoulos P; Kanetaka K; Takamura M; Shibata T; Sakamoto M; Hirohashi S
    Pancreas; 2004 Oct; 29(3):193-203. PubMed ID: 15367885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Tumor Growth and Metastasis in Pancreatic Cancer Models by Interference With CD44v6 Signaling.
    Matzke-Ogi A; Jannasch K; Shatirishvili M; Fuchs B; Chiblak S; Morton J; Tawk B; Lindner T; Sansom O; Alves F; Warth A; Schwager C; Mier W; Kleeff J; Ponta H; Abdollahi A; Orian-Rousseau V
    Gastroenterology; 2016 Feb; 150(2):513-25.e10. PubMed ID: 26597578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a new class of MDM2 inhibitor that inhibits growth of orthotopic pancreatic tumors in mice.
    Wang W; Qin JJ; Voruganti S; Wang MH; Sharma H; Patil S; Zhou J; Wang H; Mukhopadhyay D; Buolamwini JK; Zhang R
    Gastroenterology; 2014 Oct; 147(4):893-902.e2. PubMed ID: 25016295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KAI1 inhibits lymphangiogenesis and lymphatic metastasis of pancreatic cancer in vivo.
    Liu X; Guo XZ; Li HY; Chen J; Ren LN; Wu CY
    Hepatobiliary Pancreat Dis Int; 2014 Feb; 13(1):87-92. PubMed ID: 24463085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and characterization of a pancreatic carcinoma cell line derived from malignant pleural effusion.
    Starr AN; Vexler A; Marmor S; Konik D; Ashkenasi-Voghera M; Lev-Ari S; Greif Y; Ben-Yosef R
    Oncology; 2005; 69(3):239-45. PubMed ID: 16141719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, molecular and genetic validation of a murine orthotopic xenograft model of pancreatic adenocarcinoma using fresh human specimens.
    Walters DM; Stokes JB; Adair SJ; Stelow EB; Borgman CA; Lowrey BT; Xin W; Blais EM; Lee JK; Papin JA; Parsons JT; Bauer TW
    PLoS One; 2013; 8(10):e77065. PubMed ID: 24204737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a newly established human pancreatic carcinoma cell line, UK Pan-1.
    Fralix KD; Ahmed MM; Mattingly C; Swiderski C; McGrath PC; Venkatasubbarao K; Kamada N; Mohiuddin M; Strodel WE; Freeman JW
    Cancer; 2000 May; 88(9):2010-21. PubMed ID: 10813711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells.
    Liu M; Zhang Y; Yang J; Cui X; Zhou Z; Zhan H; Ding K; Tian X; Yang Z; Fung KA; Edil BH; Postier RG; Bronze MS; Fernandez-Zapico ME; Stemmler MP; Brabletz T; Li YP; Houchen CW; Li M
    Gastroenterology; 2020 Feb; 158(3):679-692.e1. PubMed ID: 31711924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients.
    Roche S; O'Neill F; Murphy J; Swan N; Meiller J; Conlon NT; Geoghegan J; Conlon K; McDermott R; Rahman R; Toomey S; Straubinger NL; Straubinger RM; O'Connor R; McVey G; Moriarty M; Clynes M
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32024004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein Kinase D1, Reduced in Human Pancreatic Tumors, Increases Secretion of Small Extracellular Vesicles From Cancer Cells That Promote Metastasis to Lung in Mice.
    Armacki M; Polaschek S; Waldenmaier M; Morawe M; Ruhland C; Schmid R; Lechel A; Tharehalli U; Steup C; Bektas Y; Li H; Kraus JM; Kestler HA; Kruger S; Ormanns S; Walther P; Eiseler T; Seufferlein T
    Gastroenterology; 2020 Sep; 159(3):1019-1035.e22. PubMed ID: 32446697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug resistance-associated protein 3 and Bcl-2 contribute to multidrug resistance by vinorelbine in lung adenocarcinoma.
    Hong X; Yang ZY; Wang M; Lu L; Li YH; Hao X; Chen GY
    Int J Mol Med; 2011 Dec; 28(6):953-60. PubMed ID: 21874222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal preservation of human pancreatic cell line derived from primary pancreatic adenocarcinoma.
    Mohammad RM; Li Y; Mohamed AN; Pettit GR; Adsay V; Vaitkevicius VK; Al-Katib AM; Sarkar FH
    Pancreas; 1999 Nov; 19(4):353-61. PubMed ID: 10547195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
    Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M
    World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and characterization of 4 new human pancreatic cancer cell lines: evidences of different tumor phenotypes.
    Chifenti B; Morelli M; Zavaglia M; Coviello DA; Guerneri S; Santucci A; Paffetti A; Masetti M; Locci MT; Bertacca G; Capodanno A; Collecchi P; Campani D; Mosca F; Bevilacqua G; Cavazzana AO
    Pancreas; 2009 Mar; 38(2):184-96. PubMed ID: 19002021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo.
    Cheng B; Wang Q; Song Y; Liu Y; Liu Y; Yang S; Li D; Zhang Y; Zhu C
    Sci Rep; 2020 Apr; 10(1):6741. PubMed ID: 32317702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.